v3.26.3
Income Taxes (Tables)
9 Months Ended
Sep. 30, 2026
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The following table summarizes the Company’s U.S. federal and state corporate-level income tax expense/(benefit), including related U.S. federal excise tax expense/(benefit), for the following periods:

For the Three Months Ended September 30,For the Nine Months Ended September 30,
2026202520262025
U.S. federal and state corporate-level income tax expense/(benefit) $2,132 $2,433 $3,829 $5,931 
U.S. federal excise tax expense2,141 2,433 3,841 5,949 
The following table presents the U.S. federal and state income tax expense/(benefit) recorded by the Company for taxable subsidiaries for the following periods:
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2026202520262025
Federal and state income tax expense/(benefit) for taxable subsidiaries $(9)$— $(12)$(18)
Schedule of Deferred Tax Assets and Liabilities
The table below presents the net deferred tax liabilities of the Company’s taxable subsidiaries, which are significantly related to GAAP-to-tax outside basis differences in the taxable subsidiaries’ investments in certain partnership interests, for the following periods:

As of September 30, 2026As of December 31, 2025
Net deferred tax assets/(liabilities)$(524)$(797)